AstraZeneca taps three banks to bridge fund $39bn Alexion buy
AstraZeneca, the UK pharmaceuticals company, has lined up $17.5bn of bridge loans from three banks to back its $39bn acquisition of US biotech firm Alexion.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: